Hunter B. Moore

Physician
AdventHealth Transplant Institute Porter
Denver, Colorado, United States

Presentation(s):

• SSC 04.3 - Fibrinolysis phenotypes during liver transplantation

  Saturday, June 22, 2024
  14:50 – 15:05 ICT

• SSC 09.7 - Shock-induced endotheliopathy- from bench to bedside

  Sunday, June 23, 2024
  17:40 – 17:55 ICT

• OC 47.3 - Tissue Plasminogen Activator (tPA)-Challenge Thrombelastography (TEG) is a Quantitative Measure of Fibrinolytic Inhibitors with Mortality Risk Implications

  Monday, June 24, 2024
  15:15 – 15:30 ICT

• SOA 17.3 - Use of TXA in the acute surgical setting

  Tuesday, June 25, 2024
  08:50 – 09:10 ICT

• OC 77.2 - Thrombelastography-estimated functional fibrinogen function in healthy volunteers, ESRD, and trauma: inaccurate when most needed

  Wednesday, June 26, 2024
  10:30 – 10:45 ICT